In neurodegenerative diseases, it remains unclear why certain brain regions are selectively vulnerable to protein aggregation. In transgenic mice expressing human A53T α-synuclein, the brainstem and spinal cord develop the most prominent α-synuclein inclusions which correlate with age-dependent motor dysfunction. Herein we present the novel finding that this selective aggregation is in part dependent on the inability of chaperone-mediated autophagy (CMA) to effectively degrade α-synuclein in these brain regions. Lysosomal assays revealed that CMA activity was significantly decreased in aggregation-prone regions compared to the remainder of the brain. Previously, CMA activity has been shown to be proportional to levels of the CMA receptor Lamp-2a. Using antibodies, brain tissue from Lamp-2a null mice, enzymatic deglycosylation, and mass spectrometry, we identified Lamp2a as a novel 72 kDa glycoprotein in the mouse brain. Examination of Lamp-2a levels revealed differences in expression across brain regions. The brainstem and the spinal cord had a more than three-fold greater levels of Lamp-2a as compared to regions less vulnerable to aggregation and exhibited a selective upregulation of Lamp-2a during development of α-synuclein inclusions. Despite this dynamic response of Lamp-2a, the levels of substrates bound to the brain lysosomes as well as the rates of substrate uptake and degradation were not proportional to the levels of Lamp-2a. These regional differences in CMA activity and Lamp-2a expression were found in both non-transgenic mice as well as A53T α-syn mice. Therefore, these are inherent variations and not a transgene-specific effect. However, differences in CMA activity may render select brain regions vulnerable to homeostatic dysfunction in the presence of stressors such as overexpression of human A53T α-syn. Collectively, the data provide a potential mechanism to explain the dichotomy of vulnerability or resistance that underlies brain regions during aggregate formation in neurodegenerative disease.
Introduction α-Synuclein (α-syn) has been identified as an integral component of the protein inclusions found in several related neurodegenerative disorders, including Parkinson's disease (PD) (Spillantini et al., 1997 (Spillantini et al., , 1998a (Spillantini et al., , 1998b . Although α-syn is expressed throughout the brain and in many other organs, inclusions are found predominantly in select brain regions (Uéda et al., 1993; Iwai et al., 1995; Duda et al., 2002) . The aggregation of α-syn is in part facilitated by protein levels, evidenced by in vitro studies as well as cases of familial PD with increased gene dosage (Conway et al., 1998; Giasson et al., 1999; Chartier-Harlin et al., 2004) . While much research has consequently focused on the protein degradation pathways that dictate α-syn homeostasis, these pathways are ubiquitously expressed. Therefore, the molecular mechanisms underlying the vulnerability of distinct brain regions to neurodegeneration remain unknown.
Recently, it has been shown in healthy mice that the ubiquitin proteasome system (UPS) is predominantly involved in clearance of α-syn. However, with increased age and α-syn expression, the UPS is impaired and the autophagy pathways are recruited (EbrahimiFakhari et al., 2011) . This highlights the interplay of various degradation systems and the relevance of autophagic degradation of α-syn in the ultimate development of disease. However, it remains unclear how dysfunction of protein degradation contributes to the regionally and temporally selective aggregation of α-syn. α-Syn has been shown to be preferentially degraded by CMA in vitro (Cuervo et al., 2004) . In CMA, cytosolic proteins containing a pentapeptide targeting motif are selectively recognized by the chaperone heat shock cognate protein 70 kDa (hsc70). Hsc70 targets the substrate to the lysosomal receptor lysosome-associated membrane 
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